Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout
https://doi.org/10.14412/1996-7012-2007-436
Abstract
Material i metody. V issledovanie vklyucheny 202 muzhchiny, stradayushchikh podagroy (kriterii S.L. Wallace). Laboratornye issledovaniya provodili posle kupirovaniya pristupa artrita. U vsekh bol'nykh otsenivali antropometricheskie pokazateli, syvorotochnye urovni mochevoy kisloty, pokazateli lipidnogo obmena. MS diagnostirovali na osnovanii rabochikh kriteriev ekspertov Natsional'nogo instituta zdorov'ya SShA (ATR III). Insulinorezistentnost' (IR) otsenivali s pomoshch'yu indeksa NOMA (Homeostasis Model Assessment). Bol'nye byli raspredeleny na gruppy (<40 let, 40-49 let, 50-59let i ≥60 let).
Rezul'taty issledovaniya. MS diagnostirovan u 67,8% bol'nykh podagroy. Chastota vyyavleniya MS v gruppakh byla sopostavimoy (65% - u bol'nykh <40 let, 70% - u bol'nykh 40-49 let, 64% - u bol'nykh 50-59 let i 73% - u bol'nykh ≥60 let). Vyyavlena pryamaya korrelyatsiya vozrasta s SAD (R=0,24, p=0,0009), DAD (R=0,32, p<0,0001), syvorotochnym urovnem glyukozy (R=0,22, p=0,0083) i obratnaya korrelyatsiya vozrasta s massoy tela (R= -0,28, p=0,0007) i syvorotochnym urovnem triglitseridov (R= -0,20, p=0,0083).
Zaklyuchenie. Chastota vyyavleniya u bol'nykh podagroy MS i IR ne zavisit ot vozrasta. Polucheny dannye, svidetel'stvuyushchie o nalichii vozrastnykh osobennostey MS u bol'nykh podagroy: u molodykh bol'nykh nablyudaetsya bol'shaya vyrazhennost' ozhireniya i gipertriglitseridemii, u pozhilykh narastaet chastota arterial'noy gipertenzii i giperglikemii.
References
1.
Review
For citations:
Nasonova VA, Eliseev MS, Barskova VG, Nasonova VA, Yeliseyev MS, Barskova VG. Impact of age on the frequency and magnitude of the signs of metabolic syndrome in patients with gout. Sovremennaya Revmatologiya=Modern Rheumatology Journal. 2007;1(1):31-36. (In Russ.) https://doi.org/10.14412/1996-7012-2007-436